These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5531105)

  • 21. Resistance of Semliki forest virus protein synthesis to high salt treatment.
    Erdei S
    Acta Virol; 1981 Sep; 25(5):257-65. PubMed ID: 6118045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional significance of the nuclear-targeting and NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2.
    Rikkonen M
    Virology; 1996 Apr; 218(2):352-61. PubMed ID: 8610462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of cordycepin on the multiplication of Semliki Forest virus and on polyadenylation of viral RNA.
    Wittek R; Koblet H; Menna A; Wyler R
    Arch Virol; 1977; 54(1-2):95-106. PubMed ID: 302113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of interferon action by puromycin.
    Friedman RM; Sonnabend JA
    J Immunol; 1965 Oct; 95(4):696-703. PubMed ID: 5841055
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of streptovaricin on the incorporation of uridine into cellular and viral RNA.
    Tan KB; McAuslan BR
    Chem Biol Interact; 1977 Mar; 16(3):347-57. PubMed ID: 16701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Entry of Semliki forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection.
    Irurzun A; Nieva JL; Carrasco L
    Virology; 1997 Jan; 227(2):488-92. PubMed ID: 9018148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant methylation and synthesis in vitro of Semliki Forest virus (SFV) ss RNAs by a fraction from infected cells.
    Cross RK; Gomatos PJ
    Virology; 1981 Oct; 114(2):542-54. PubMed ID: 6170159
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability.
    Casales E; Rodriguez-Madoz JR; Ruiz-Guillen M; Razquin N; Cuevas Y; Prieto J; Smerdou C
    Virology; 2008 Jun; 376(1):242-51. PubMed ID: 18442838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens.
    Smith ML; Corbo T; Bernales J; Lindbo JA; Pogue GP; Palmer KE; McCormick AA
    Virology; 2007 Feb; 358(2):321-33. PubMed ID: 17014881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementation in 26 S RNA synthesis between temperature-sensitive mutants of Semliki Forest virus.
    Keränen S
    FEBS Lett; 1977 Aug; 80(1):164-8. PubMed ID: 560998
    [No Abstract]   [Full Text] [Related]  

  • 31. 1,3-Diaminopropane rapidly inhibits protein synthesis and virus production in BKT-1 cells.
    Tuomi K; Raina A; Mäntyjärvi R
    FEBS Lett; 1980 Mar; 111(2):329-32. PubMed ID: 7358176
    [No Abstract]   [Full Text] [Related]  

  • 32. High-level expression of rabies virus glycoprotein with the RNA-based Semliki Forest Virus expression vector.
    Benmaamar R; Astray RM; Wagner R; Pereira CA
    J Biotechnol; 2009 Feb; 139(4):283-90. PubMed ID: 19135103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two ways to induce innate immune responses in human PBMCs: paracrine stimulation of IFN-alpha responses by viral protein or dsRNA.
    Fournier P; Zeng J; Schirrmacher V
    Int J Oncol; 2003 Sep; 23(3):673-80. PubMed ID: 12888903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth and stability of a cholesterol-independent Semliki Forest virus mutant in mosquitoes.
    Ahn A; Schoepp RJ; Sternberg D; Kielian M
    Virology; 1999 Sep; 262(2):452-6. PubMed ID: 10502523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple structurally related defective-interfering RNAs formed during undiluted passages of Semliki forest virus.
    Kääriäinen L; Pettersson RF; Keränen S; Lehtovaara P; Söderlund H; Ukkonen P
    Virology; 1981 Sep; 113(2):686-97. PubMed ID: 7269257
    [No Abstract]   [Full Text] [Related]  

  • 36. A luciferase-based screening method for inhibitors of alphavirus replication applied to nucleoside analogues.
    Pohjala L; Barai V; Azhayev A; Lapinjoki S; Ahola T
    Antiviral Res; 2008 Jun; 78(3):215-22. PubMed ID: 18294708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Characterization of virus-specific mRNA from cells infected with the togavirus Semliki Forest virus by translation in vitro.
    Wengler G; Beato M
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1267. PubMed ID: 4461618
    [No Abstract]   [Full Text] [Related]  

  • 38. [Interferon assay and kinetics].
    Koblet H; Kohler U; Wyler R
    Pathol Microbiol (Basel); 1972; 38(1):48-9. PubMed ID: 5063038
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of additional genes in a vector derived from a minimal RNA virus.
    Rolls MM; Haglund K; Rose JK
    Virology; 1996 Apr; 218(2):406-11. PubMed ID: 8610469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentiviral vector-derived shRNAs confer enhanced suppression of Semliki forest virus replication in BHK-21 cells compared to shRNAs expressed from plasmids.
    Zhang K; Chen Y; Pan J; Ahola T; Guo D
    Biotechnol Lett; 2009 Apr; 31(4):501-8. PubMed ID: 19116690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.